Progesterone, progestogens and psychosomatic health of the climacteric woman

Maturitas

Volumn 62, Issue 4, 2009, Pages 330-333

  Bitzer, J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Menopause; Mental health; Physical health; Progesterone; Psychosomatic health; Sexual health

Indexed keywords

CONJUGATED ESTROGEN; DYDROGESTERONE; ESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE; NORETHISTERONE ACETATE; PLACEBO; PROGESTERONE; PROGESTERONE RECEPTOR;

ANXIETY; BLEEDING; BLOATING; BRAIN; BREAST TENSION; CLIMACTERIUM; DEPRESSION; ENDOMETRIUM; HUMAN; MENTAL HEALTH; POSTMENOPAUSE; PREMENSTRUAL SYNDROME; PSYCHOSOMATICS; REVIEW; SEXUAL HEALTH;

CLIMACTERIC; ESTROGEN ANTAGONISTS; FEMALE; HEALTH; HORMONE REPLACEMENT THERAPY; HUMANS; MENTAL HEALTH; PROGESTERONE; PROGESTINS; PSYCHOPHYSIOLOGIC DISORDERS;

EID: 67349243407     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.10.008     Document Type: Review

References (13)

1. Bitzer J. Die Frau als körperlich-seelische Einheit im sozialen Kontext Frauengesundheit. In: Riecher-Rössler P.A., and Bitzer J. (Eds). Ein Leitfaden für die ärztliche und psychotherapeutische (2005), Elsevier GmbH Urban & Fischer Verlag, München 3-11
2. Klein P. Mood and the menopause. In: Studd J. (Ed). The management of menopause (2003), Parthenon Publishing Group, London 95-109
3. Oinonen K.A., and Mazmanian D. To what extent do oral contraceptives influence mood and affect?. J Affect Disord 70 Aug (3) (2002) 229-240
4. Bäckström T., Andersson A., Andreé L., Birziniece V., et al. Pathogenesis in menstrual cycle-linked CNS disorders Ann. N Y Acad Sci 1007 (2003) 42
5. Magos A.L., Brewster E., Singh R., O'Dowd T., Brincat M., and Studd J.W. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 93 Dec (12) (1986) 1290-1296
6. Hammarbäck S., Bäckström T., Holst J., von Schoultz B., and Lyrenäs S. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 64 5 (1985) 393-397
7. Michael S., Rachida G., Abdel G., et al. Etienne-Emile Baulieu: novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev 28 4 (2007) 387-439
8. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J.M., et al. Progesterone receptors: form and function in brain. Neuroendocrinology 29 May 2 (2008) 313-339
9. L Andreen, M Bixo, S Nyberg, I Sundstrom-Poromaa, and T Backstrom: Progesterone effects during sequential hormone replacement therapy European Journal of Endocrinology, Vol 148, Issue 5, 571-577.
10. Cagnacci A., Arangino S., Baldassari F., Alessandrini C., Landi S., and Volpe A. A comparison of the central effects of different progestins used in hormone replacement therapy. Maturitas 48 4 (2004) 456-462 Aug 20
11. Siddle N.C., Fraser D., Whitehead M.I., Jesinger D.K., Endacott J., Prescott P., and Pryse-Davies J. Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone. Br J Obstet Gynaecol 97 Dec (12) (1990) 1101-1107 Links
12. Rapkin A.J., Morgan M., Sogliano C., Biggio G., and Concas A. Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes. Fertil Steril 85 May (5) (2006) 1371-1378 Epub 2006 Apr 3
13. Joffe H., Cohen L.S., and Harlow B.L. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Am J Obstet Gynecol 189 Dec 6 (2003) 1523-1530